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Anti-inﬂammatory properties of cacao, fruits of Theobroma cacao L. (Sterculiaceae), are
well documented, and therapeutic applications are described for gastrointestinal, nervous,
and cardiovascular abnormalities. Most, if not all of these disease conditions involve
inﬂammation or immune activation processes. The pro-inﬂammatory cytokine interferon-
γ (IFN-γ) and related biochemical pathways like tryptophan breakdown by indoleamine
2,3-dioxygenase (IDO) and neopterin formation are deeply involved in their pathogenesis.
Neopterin concentrations and the kynurenine to tryptophan ratio (Kyn/Trp, an estimate of
IDO activity) are elevated in a signiﬁcant proportion of patients with virus infections, cancer,
autoimmune syndrome, neurodegeneration, and coronary artery disease. Moreover,
higher neopterin and Kyn/Trp concentrations are indicative for poor prognosis. When
investigating the effect of aqueous or ethanolic extracts of cacao on IFN-γ, neopterin
and Kyn/Trp concentrations in mitogen-stimulated human peripheral blood mononuclear
cells, breakdown of tryptophan by IDO, and formation of neopterin and IFN-γ were dose-
dependently suppressed. The effects observed in the cell-based assays are associated
with the antioxidant activity of the cacao extracts as determined by the cell-free oxygen
radical absorption capacity assay.The inﬂuence of cacao extracts on IDO activity could be of
particular relevance for some of the beneﬁcial health effects ascribed to cacao: tryptophan
breakdown by IDO is strongly involved in immunoregulation, and the diminished availability
of tryptophan limits the biosynthesis of neurotransmitter serotonin. The inhibition of
tryptophan breakdown by cacao constituents could thus be relevant not only for immune
system restoration in patients, but also contribute to mood elevation and thereby improve
quality of life. However, the available data thus far aremerely in vitro only and future studies
need to investigate the inﬂuence of cacao on tryptophan metabolism in vivo.
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INTRODUCTION
Epidemiological studies suggest that high dietary intake of sec-
ondary plant metabolites is associated with a decreased risk of
diseases like cardiovascular disorders or cancer (Surh, 2003). Tea,
coffee and cocoa, fruits and vegetable are rich in polyphenols, a
complex group of substances that gained considerable interested
due to their antioxidative properties, thus supporting potential
beneﬁcial implications on human health. Meanwhile, more than
8000 different phenolic structures have been identiﬁed (Bravo,
1998).
Cocoa is the term for unroasted fruits (beans) of the evergreen
cacao tree Theobroma cacao L. (Sterculiaceae or alternatively Mal-
vaceae). After grinding of the cocoa seeds, the cocoa butter is
removed from the dark, bitter cocoa solids. The consumption of
cocoa can be dated back to the preclassic Maya as early as 600 B.C.
(Hurst et al., 2002). Drinking of beverages prepared with cocoa for
therapeutic purpose was very popular in Olmec, Maya, and Aztec
cultures. According to tradition, liquid cocoa is a divine drink,
which builds up resistance and ﬁghts fatigue. “A cup of this pre-
cious drink permits a man to walk for a whole day without food”
(traditional citation of Hernán Cortés, 1519; Corti et al., 2009).
Until today, cocoa consumption is associated with regalement and
a sense of delight. The most known applications of cocoa for
medicinal purposes arise from appetite stimulating, relaxing, and
mood-enhancing effects.
Also, cacao-rich chocolate has been known for centuries and
although common processing strategies of cocoa beans, such as
roasting or fermentation, reduce the amount of some bioactive
constituents (Payne et al., 2010), dark chocolate consumption has
been suggested to promote beneﬁcial effects on human health
(Engler et al., 2004), whereby the content of low molecular weight
ﬂavanols, e.g., of epicatechin, is supposed to be of particular
importance.
The discovery of a wide range of biologically active substances
has changed the perception of cocoa/cacao as stimulant or lux-
ury food only, and several in vitro and in vivo studies suggest
that some identiﬁed active compounds exhibit pharmacologic
effects with potential health implications. A large number of
studies reported on beneﬁt exerted by cacao/cocoa extracts and
constituents on processes involved in inﬂammation or impaired
immune functions, ageing, blood pressure regulation, atheroscle-
rosis, or cardiovascular diseases development (Galleano et al.,
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2009; van Dam et al., 2013; Williams, 2013). Cocoa compounds
were shown to inﬂuence on, e.g., platelet activation (Rein et al.,
2000) and nitric oxide (NO)-dependent activities (Fisher et al.,
2003; Heiss et al., 2003) as well as on cytokine production in vivo.
Furthermore, a beneﬁcial effect of cocoa consumption on blood
pressure (Grassi et al., 2010), insulin resistance, and vascular and
platelet function has been suggested (Corti et al., 2009; Galleano
et al., 2009).
Among the most discussed effects of cacao/cocoa uptake
are interferences with vascular function, platelet reactivity and
inﬂammatory processes, suggesting cardioprotective properties
of some constituents (Keen et al., 2005). A variety of envi-
ronmental and genetic factors may have inﬂuence on cardio-
vascular disease development, and several pathological changes
may lead to dysfunction of pathways that are involved in
the maintenance of cellular and tissue homeostasis, promot-
ing conditions of oxidative stress (Ramsey et al., 2010). The
“oxidative modiﬁcation hypothesis” describes an important
process in atherosclerosis disease development, where lipids
and proteins of the vessel wall and low-density lipoprotein
(LDL) are oxidized in an early stage of the disease. The
accumulation of lipids in the arterial wall leads to chronic
inﬂammation. It is accompanied by thickening and harden-
ing of the vessel wall, which lowers elasticity and results in
impaired blood ﬂow (Brigelius-Flohé et al., 2005). However,
pathological changes occur long before diseases are diagnosed,
making it difﬁcult to treat real primary causes rather than
symptoms.
Among the major mechanisms that contribute to the potential
cardioprotective effects of cocoa ﬂavanols are their direct and indi-
rect antioxidative properties. The high dietary intake of antioxi-
dant compounds is suggested to decrease the atherosclerotic risk
by attenuating oxidation processes (Brigelius-Flohé et al., 2005)
and/or by interfering with cellular signaling pathways (Schroeck-
snadel et al., 2007; Stevenson and Hurst, 2007). Still, the correla-
tion between antioxidant intake and reduction of cardiovascular
disease is challenging (Joshipura et al., 2001; Galleano et al., 2009)
and also, the prevention of LDL oxidation by antioxidants is
controversially discussed in literature (van de Vijver et al., 1997;
Brigelius-Flohé et al., 2005).
However, the inﬂammatory background in disease develop-
ment, like the starting point of pro-inﬂammatory cytokine release
and metabolite production, is a central target for preventive
actions. In line with this, we aim to discuss potential interfer-
ences of cacao/cocoa antioxidants with central immunoregulatory
mechanisms, by focusing on pathways involved in cell-mediated
immune response.
ANTIOXIDANT CONTENT OF COCOA/CACAO
Antioxidants are reducing chemicals that are able to inhibit or
prevent oxidation processes of molecules by being oxidized them-
selves. An antioxidant can also be a radical scavenger, which can
transform itself into a rather inert radical, and terminates radical-
driven chain reactions (Brigelius-Flohé et al., 2005). Antioxidant
compounds may be produced within the human body or can
be absorbed from dietary intake. Most plants and herbs are rich
sources of antioxidant molecules and numerous epidemiological
studies were made investigating the potential radical scaveng-
ing potential of plant-derived phenols and polyphenols in vivo
(Albarracin et al., 2012).
Cocoa/cacao contains remarkable amounts of total phenolics
and ﬂavonoids in comparison to other fruits and vegetables. The
phenolic content of roasted cocoa beans can account for up to
18% of total weight, with catechins and ﬂavan-3-ols, antho-
cyanins, and proanthocyanidins as major groups (Rusconi and
Conti, 2010). In particular epicatechin, catechin, gallocatechin,
and epigallocatechin are contained in high concentrations. The
ﬂavanol content (catechin and epicatechin content) of chocolate
is 460–610 mg/kg and thus comparable to that in green tea and
beans (Corti et al., 2009). In summary, over 380 compounds of
cocoa have been identiﬁed, including theobromine and caffeine
(at low levels), as well as 10 psychoactive compounds (Rusconi
and Conti, 2010).
Both, the ﬂavanol content and the total antioxidant capacity
increases in plasma after oral intake of cocoa or dark chocolate
(Seraﬁni et al., 2003; Spadafranca et al., 2010). Consumption of
cacao in combination with milk or milk chocolate was shown to
reduce these effects dramatically, although suchmatrix-dependent
absorption effects are still matter of discussion (Corti et al., 2009).
Miller et al. (2006), compared cacao and popular chocolate
products with the oxygen radical absorbance capacity test (ORAC)
and determined polyphenol and procyanidin contents. Natural
cocoa powders contained the highest levels of antioxidant capac-
ity (720 and 875 μmol Trolox equivalents/g) as well as higher
total polyphenols and procyanidins, compared to other products
(Miller et al., 2006). Of course, food processing such as roasting,
fermentation, or conventional chocolate manufacturing leads to
a decrease of antioxidant content (Corti et al., 2009; Payne et al.,
2010).
Several antioxidants have also the capacity to inﬂuence cellular
signaling pathways and thus activate the expression of protec-
tive, antioxidant or immunoregulatory genes. Experiments of
Rodríguez-Ramiro et al. (2011) demonstrated that cocoa pheno-
lic extracts can improve the redox status of acrylamide-treated
Caco-2 intestinal carcinoma cells by inhibiting glutathione con-
sumption and reactive oxygen species (ROS) generation, by
increasing the levels of gamma-glutamylcysteine synthetase and
glutathione-S-transferase and by blocking of apoptotic pathways.
It can be suggested that, e.g., the reduction of lipid and inﬂam-
matory biomarkers in hypertension by some cocoa-containing
products (Solà et al., 2012) is a concerted action of both, direct
and indirect antioxidant properties of cocoa/cacao.
INTERFERENCES OF COCOA/CACAO EXTRACTS WITH
CELL-MEDIATED IMMUNE RESPONSE
Various immunocompetent cells and mediators are involved in the
regulation and modulation of immunological reactions, and espe-
cially the interaction of lymphocytes and macrophages plays an
important role (Balakrishnan and Adams, 1995). Different types
of immune responses are completed by distinct subsets of T-helper
(Th) cells like Th1-, Th2-, and Th17-type cells (Romagnani, 2006;
Jin et al., 2012). During Th1-type (=cell-mediated) immune
response, the pro-inﬂammatory cytokines interferon-γ (IFN-γ),
and interleukin-2 (IL-2) are produced by activated T and natural
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killer cells to mount an effective response against pathogens and
tumor cells, while allergic Th2-type cell responses are charac-
terized by cytokines IL-4, IL-5, and IL-13 (Barth et al., 2003;
Romagnani, 2004). In a kind of cross-regulation, Th1-type
cytokines can suppress the Th2-type immune response and vice
versa (Lucey et al., 1996).
Interferon-γ plays a prominent role in host defense and stim-
ulates cellular responses, such as production of high amount of
ROS by macrophages (Nathan, 1986). Toxic ROS products, as
hydrogen peroxide (H2O2), hypochlorite (OCl−), and super-
oxide anion radical (O−2 ), suppress growth of target cells and
pathogens. In inﬂamed tissue, increased formation of ROS leads
to the disruption of protective cellular antioxidant mechanisms,
which results in a milieu also called oxidative stress (Bowler
and Crapo, 2002). Further, mitogen-activated protein kinase
(MAPK), transcription factor nuclear factor-κB (NF-κB), and
activator protein (AP)-1-dependent signaling cascades become
activated and modulate the expression of pro-inﬂammatory
cytokines, such as tumor necrosis factor-α (TNF-α) and IL-1,
chemokines, and adhesion molecules (Aggarwal, 2004). NF-κB
is highly inducible by oxidants and a key molecule of the pro-
inﬂammatory signaling cascade that regulates the transcription
of cytokines, chemokines, growth factors, adhesion molecules,
immunoreceptors, and acute phase proteins (Asehnoune et al.,
2004).
These redox-sensitive pathways regulate initiation, execution,
and resolution of the inﬂammatory response. Thus, interfer-
ences of dietary antioxidants with ROS signaling in inﬂamed
tissues might protect against cellular damage (Schroecksnadel
et al., 2007). However, antioxidants, when supplemented in high
dose, can also be unfavorable and shift Th1-type immune response
toward Th2-type, promoting allergic diseases (Zaknun et al.,
2012).
In several in vitro studies, cacao extracts were shown to
down-regulate pro-inﬂammatory cytokines and their downstream
biochemical pathways (Corti et al., 2009; Galleano et al., 2009).
Ramiro et al. (2005) reported that cocoa extracts and epicatechin
decreased the expression of TNF-α, monocyte chemoattractant
protein 1 (MCP-1) and other cytokines, as well as NO release in
macrophages. Zeng et al. (2011) reported an inhibition of O−2 pro-
duction, cytokine release, and NF-κB activation after clovamide (a
phenylpropenic acid amide present in cocoa) treatment in PMA
(phorbol 12-myristate 13-acetate)-stimulated human monocytes.
Application of phenolic extracts fromunroasted and roasted cocoa
beans showed similar but less strong effects.
A central immunoregulatory pathway induced by IFN-γ in
human monocytes/macrophages is the breakdown of the essen-
tial amino acid tryptophan via the enzyme indoleamine 2,3-
dioxygenase (IDO). Unlike the hepatic isoenzyme tryptophan
2,3-dioxygenase (TDO), IDO is expressed in a variety of cell types
such as macrophages, ﬁbroblasts, epithelial and endothelial cells,
and cells of the central nervous system. IDO expression and activ-
ity is drastically increased during inﬂammation (Schröcksnadel
et al., 2006b). About 95% of dietary tryptophan is degraded via
the kynurenine pathway, leading to the formation of L-kynurenine
and further downstream products kynurenic acid, anthranilic
acid, 3-hydroxykynurenine, quinolinic acid, picolinic acid, and
nicotinamide adenine dinucleotide (NAD+; Adams et al., 2012;
Figure 1). Another metabolic route of tryptophan is the serotonin
pathway, in which tryptophan is hydroxylated via the rate-limiting
enzyme tryptophan 5-hydroxylase (T5H) to 5-hydroxytrytophan
and serotonin (5-hydroxytryptamin, 5-HT). Therefore, trypto-
phan availability is strongly involved in the pathogenesis of mood
disorders and depression (Widner et al., 2002), as an insufﬁcient
tryptophan concentration may cause neuropsychiatric symptoms
when serotonin production is diminished (Widner et al., 2000).
FIGURE 1 |The essential amino acid tryptophan is required for protein
biosynthesis or is metabolized via two biochemical routes: (i) via
tryptophan 5-hydroxylase (T5H) and subsequent decarboxylation to
5-hydroxytrytophan and serotonin, and (ii) via tryptophan 2,3-dioxygenase
(TDO) and indoleamine 2,3-dioxygenase (IDO) to kynurenine, which is fur-
ther converted to several metabolites (adapted fromWidner et al., 2002).
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The IDO-induced tryptophan breakdown is an important
defense strategy to prevent undesired growth, e.g., of intracel-
lular pathogens such as viruses, parasites, and bacteria, but also
tumor cells (Pfefferkorn, 1986). In various diseases that are associ-
ated with cellular immune activation, decreased tryptophan levels
together with increased kynurenine to tryptophan ratio (Kyn/Trp)
ratio are found. Kyn/Trp indicates that the low amount of tryp-
tophan results from enhanced degradation rather than from a
reduced dietary intake (Fuchs et al., 1990).
In parallel to IDO, IFN-γ activates the formation of the pteri-
dine derivative neopterin, by the enzyme guanosine triphosphate
(GTP)-cyclohydrolase (GCH; Werner et al., 1989). Neopterin is a
sensitive marker for activation of the immune system that has
been identiﬁed in the early 1980s (Fuchs et al., 1982; Werner
et al., 1987). The biosynthesis of neopterin starts from GTP,
which is converted to 7,8-dihydroneopterintriphosphate by GCH.
Due to a deﬁciency of the tetrahydrobiopterin (BH4)-forming
enzyme 6-pyruvoyltetrahydropterin synthase (PTPS) of human
macrophages and dendritic cells, the biosynthesis of BH4 is pre-
vented and neopterin is produced (Werner et al., 1990; Figure 2).
Other cell types like human endothelial cells and B-lymphocytes
have been shown to be able to produce low amounts of neopterin,
however, not comparable with the production of neopterin in
macrophages (Andert et al., 1992; Hofmann et al., 1992).
Of note, BH4 is required as a cofactor of several enzymes
such as T5H and inducible NO synthase (iNOS). Due to insuf-
ﬁcient BH4 production, human monocyte-derived macrophages
and dendritic cells are limited in the formation and release
of NO and peroxynitrite (ONOO−; Murr et al., 2002). Some
studies have shown that diseases with an inﬂammatory back-
ground can have endogenous NO formation and high serum
neopterin levels together. This occurs probably by the stim-
ulation of NOS in other cell types, e.g., endothelial cells
(Weiss et al., 1995).
High neopterin concentrations reﬂect IFN-γ activity and thus
can serve as a biochemical indicator of immune activation (Fuchs
et al., 1992; Schroecksnadel et al., 2006a; Schröcksnadel et al.,
2006b). High neopterin levels have been shown to be associated
FIGURE 2 | In various cells theTh1-type cytokine interferon-γ (IFN-γ)
induces the GTP-cyclohydrolase I (GCH I) to produce 7,8-
dihydroneopterintriphosphate. Due to a deﬁciency in
pyruvoyltetrahydropterin synthase (PTPS) in human monocyte-derived
macrophages and dendritic cells, the production of 5,6,7,8-
tetrahydrobiopterin is almost zero and neopterin is produced in high
concentrations.
with a strong release of ROS in activated macrophages (Nathan,
1986). Accordingly, in various diseases, neopterin concentra-
tions correlate with serum low concentrations of antioxidants
(Murr et al., 2009). Therefore, neopterin may also represent an
indirect sensitive indicator of oxidative stress during immune
activation (Murr et al., 1999). In line with this, high neopterin
concentrations were shown to indicate increased production
of ROS in cancer patients (Murr et al., 1999; Hronek et al.,
2000). Furthermore, tryptophan breakdown and neopterin for-
mation served as readout to monitor and predict survival in
cardiovascular diseases (Grammer et al., 2009; Pedersen et al.,
2011).
Neopterin itself seems to accompany not only oxidative stress,
but has also the ability to interact with ROS. Chemiluminescence
experiments revealed that neopterin increases effects of reactive
compounds such as H2O2, OCl−, chloramine, and ONOO−,
whereas is sister compound7,8-dihydroneopterin can act as a scav-
enger (Weiss et al., 1993). Cirillo et al. (2006) and Hofmann et al.
(1992) reported that neopterin is able to induce the translocation
of NF-κB in human endothelial cells and vascular smooth muscle
cells.
Aqueous extracts of cacao were found to signiﬁcantly suppress
tryptophan breakdown and neopterin formation in a dose-
dependent manner in vitro (Jenny et al., 2009). In the experiments,
neopterin formation was induced in human peripheral blood
mononuclear cells (PBMCs) by the mitogen phythemaglutinin
(PHA), treatment with cacao extract at non-toxic concentrations
was able to inhibit tryptophan breakdown completely such that
tryptophan concentration in the culture media returned to base-
line (Figure 3). Furthermore, the formation of neopterin and
IFN-γ was signiﬁcantly suppressed. This result indicates poten-
tial anti-inﬂammatory and cell protective properties of cacao.
The extracts of several plants and herbs used in traditional folk
medicine like Crinum latifolium,Camellia sinensis (Zvetkova et al.,
2001), or Hypericum perforatum (Winkler et al., 2004) had similar
activities to suppress Th1-type immune activation pathways like
production of IFN-γ and neopterin in PBMC system. These ﬁnd-
ings agree with the properties of other antioxidant components
such as vitamins or antioxidant drugs, which also have suppressive
effects on activated immune cells (Jenny et al., 2011).
Of note, treatment of myelomonocytic THP-1 cells with cacao
extracts did not result in a reduction of lipopolysaccharide (LPS)-
induced neopterin formation or tryptophan breakdown. Thus,
the suppressive effects of cacao extracts are suggested to be exerted
rather on T-cells signaling and IFN-γ production than on isolated
macrophages (Jenny et al., 2009).
CACAO AND MOOD DISORDERS
Patients with chronic diseases like infections, autoimmune dis-
eases or cancer, have an increased risk for the development of
mood disorders. Reasons can be either the poor or impaired
future perspectives, but also the metabolic changes that are asso-
ciated with diseases (Capuron et al., 2002; Widner et al., 2002).
Depressive symptoms can also develop as side effects in patients
under treatment with pro-inﬂammatory cytokines as interleukins,
interferons. All these conditions indicate a close connection
of cytokine-induced biochemical changes and development of
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FIGURE 3 | Mean neopterin and tryptophan concentrations in mitogen
(PHA)-stimulated freshly isolated peripheral blood mononuclear cells
(PBMCs), either treated with 10 μg/ml aqueous cacao extracts or left
untreated, compared to unstimulated controls. The results are shown
in % of the baseline in the supernatants of unstimulated PBMC.
Experiments were run in duplicates and in four independent approaches
[**p < 0.05 compared to unstimulated cells; #p < 0.05 compared to
stimulated cells; adapted from Jenny et al. (2009)].
neuropsychiatric symptoms (Capuron et al., 2003; Dantzer and
Kelley, 2007).
Dysfunctions of neurotransmitter, hormone and vitamin syn-
thesis and metabolism are involved in the pathogenesis of
depressive disorders. For example, reduced concentration of
5-hydroxyindoleacetic acid, the main catabolite of serotonin,
indicates insufﬁcient serotonin availability. Selective serotonin-
reuptake inhibitors (SSRIs) can counteract low levels of neuro-
transmitters and are frequently used in the treatment of anxiety
andmooddisorders (DeVane,1998), althoughnot always effective.
The neurotransmitter serotonin, dopamine, and nore-
pinephrine share similarities in their synthesis, e.g., all of them
are depending on enzymes that require BH4 as cofactor. A close
relationship between high neopterin levels and BH4 biochem-
istry can be constructed with the critical involvement of BH4
in the biosynthesis of biogenic amines like serotonin and several
adrenergic/dopaminergic neurotransmitters. This relationship is
further supported by associated occurrences of these immuno-
logical markers and neuropsychiatric symptoms (Neurauter et al.,
2008), e.g., patient suffering from seasonal affective disorders were
shown to have low plasma levels of tryptophan and biopterin (a
BH4 product), but elevated neopterin concentrations (Hoekstra
et al., 2003).
During inﬂammation, the activated tryptophan breakdown
leads to insufﬁcient serotonin biosynthesis, which can increase
the development of mood disturbances and depression and fur-
thermore may inﬂuence cognitive functions (Neurauter et al.,
2008). Also, tryptophan breakdown products such as 3-
hydroxyanthranillic acid and quinolinic acid may negatively affect
neurological functions, while other metabolites such as kynurenic
acid can be neuroprotective (Heyes et al., 1992; Sas et al., 2007;
Klein et al., 2013). Furthermore, an excess in ROS, which is
produced during immune response, can interrupt the oxidation
sensitive pathways like serotonin production.
A variety of clinical studies and experimental data have shown
that tryptophan levels are low and neopterin levels are increased
in patients with depression. These results support the hypothesis
that the immune response plays a major role in development of
depression (Maes et al., 1994; Murr et al., 2000).
Depression also develops in most of the IFN-α and/or IL-2
cytokine therapies (Capuron et al., 2003). During these ther-
apies, a signiﬁcant decrease of tryptophan concentrations can
be monitored and also the ratio of tryptophan to large neu-
tral amino acids like tyrosine, phenylalanine, leucine, and
isoleucine is affected. These amino acids are known to cor-
relate with depressive symptoms (Capuron et al., 2002, 2011).
Thus, depressive disorders might represent a result of the tryp-
tophan depletion which affects downstream pathways at multiple
levels.
Due to its strong anti-inﬂammatory effects, cacao can inﬂuence
on IDO activity as it has been shown in vitro, were treatment
of mitogen-stimulated PBMC with cacao extracts resulted in an
inhibition of tryptophan breakdown and neopterin formation in a
dose-dependent manner (Jenny et al., 2009). Similar effects could
possibly occur also in vivo and contribute to a mood-enhancing
effect by improving tryptophan availability for serotonin synthesis.
The capacity to improve mood, lift spirits and make people
feel good has been described for cocoa, cacao, and chocolate
products. Chocolate was reported to have an antidepressant ben-
eﬁt on humans, to be a kind of self-medication in an atypical
or a seasonal depression and to have a positive impact on brain
neurotransmitters. Chocolate craving has some addictive features,
and some psychoactive ingredients have been identiﬁed, like the
biogenic stimulant amines caffeine, theobromine, tyramine, and
phenylethylamine. However, the concentrations of these com-
pounds in cacao are not that high and this effect cannot be
attributed to them alone (Parker et al., 2006). Nevertheless, cacao
can be a kind of indirect oral tryptophan supplementation by
inhibiting IDO activity.
Several cocoa constituents have been reported to reach the
gastrointestinal tract. It was shown that, e.g., most ingested pro-
cyanidins arrive intact in the small intestine and are available for
absorption or metabolism (Rios et al., 2002). Flavan-3-ol metabo-
lites could be detected in plasma and serum after consumption
of cocoa beverages (Mullen et al., 2009). These substances can
accumulate at relatively high concentrations in the gastrointesti-
nal tract, and an interference with tryptophan metabolism via
the inhibition of IDO and consequently the disposability of sero-
tonin (Figure 4) might be proposed. The gut is not only rich
in the number of lymphocytes, about 95% of the human sero-
tonin is synthesized and stored in the gastrointestinal tract, where
it acts as a paracrine messenger to modulate sensation, secre-
tion, and motility (Gershon and Tack, 2007). Another inﬂuence
on neurological functions was reported by Bisson et al. (2008)
who reported a decrease of cognitive impairments, which occur
normally in aged rats, after long-term treatment with cocoa
extracts.
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FIGURE 4 | During Th1-type immune response, activated T-cells and
natural killer (NK) cells release large amounts of the inflammatory
cytokine interferon-γ (IFN-γ), which triggers various immunoregulatory
and anti-proliferative activities in target cells like macrophages (M)
and dendritic cells (DC). Indoleamine 2,3-dioxygenase (IDO) converts
tryptophan into kynurenine. In parallel GTP-cyclohydrolase I (GCH) is
induced to produce neopterin out of GTP. Neopterin plays a major role in
the release of reactive oxygen species (ROS) in human macrophages. When
oxidative stress is rising to higher levels, transcription factor nuclear
factor-κB (NF-κB) becomes activated and induces the pro-inﬂammatory
signaling pathways. Cacao, acting as an antioxidant, can inﬂuence and
counteract against these cascades.
CONCLUSION
Diseases accompanied by chronic inﬂammation are frequently
associated with depressive symptoms and mood disorders. Cellu-
lar immune activation is characterized by accelerated tryptophan
breakdown and increased neopterin formation, which both can
be used as sensitive biomarkers in vitro and in vivo. Tryptophan
is degraded via IDO to kynurenine, which can further be metabo-
lized to neuroactive products. Additionally, tryptophan is utilized
for serotonin synthesis.
Cacao has the ability to decrease tryptophan breakdown,
neopterin formation, and the concentration of other inﬂamma-
tory markers under certain experimental conditions. Beneﬁcial
effects of cacao/cocoa could be expected if the breakdown of tryp-
tophan can be rescued also in vivo, to guarantee enough trypto-
phan for the serotonin production. Antioxidant constituents could
further decrease oxidative stress and interferewith redox-regulated
pathways.
Nevertheless, it should keep in mind that most of the reported
studies on cocoa/cacao compounds and extracts were performed
in vitro only, and a direct extrapolation to the in vivo is not possi-
ble. Furthermore, although also processed cocoa products such as
chocolate or cacao still contain a number of bioactive substances,
these processed products are usually ingested within a complex
food matrix and health effects are not always identical with natural
cocoa extracts.
REFERENCES
Adams, S., Braidy, N., Bessede, A., Brew, B. J., Grant, R., Teo, C., et al. (2012). The
kynurenine pathway in brain tumor pathogenesis. Cancer Res. 72, 5649–5657.
doi: 10.1158/0008-5472.CAN-12-0549
Aggarwal, B. B. (2004). Nuclear factor-kappaB: the enemy within. Cancer Cell 6,
203–208. doi: 10.1016/j.ccr.2004.09.003
Albarracin, S. L., Stab, B., Casas, Z., Sutachan, J. J., Samudio, I., Gonzalez, J.,
et al. (2012). Effects of natural antioxidants in neurodegenerative disease. Nutr.
Neurosci. 15, 1–9 doi: 10.1179/1476830511Y.0000000028
Andert, S. E., Griesmacher, A., Zuckermann, A., and Müller, M. M. (1992).
Neopterin release fromhuman endothelial cells is triggered by interferon-gamma.
Clin. Exp. Immunol. 88, 555–558. doi: 10.1111/j.1365-2249.1992.tb06486.x
Asehnoune,K., Strassheim,D.,Mitra, S., Kim, J.Y., andAbraham, E. (2004). Involve-
ment of reactive oxygen species in Toll-like receptor 4-dependent activation of
NF-kappa B. J. Immunol. 172, 2522–2529.
Balakrishnan, K., andAdams, L. E. (1995). The role of the lymphocyte in an immune
response. Immunol. Invest. 24, 233–244. doi: 10.3109/08820139509062775
Barth, H., Berg, P. A., and Klein, R. (2003). Methods for the in vitro determination
of an individual disposition towards TH1- or TH2-reactivity by the applica-
tion of appropriate stimulatory antigens. Clin. Exp. Immunol. 134, 78–85. doi:
10.1046/j.1365-2249.2003.02265
Bisson, J. F., Nejdi, A., Rozan, P., Hidalgo, S., Lalonde, R., Messaoudi, M., et al.
(2008). Effects of long-term administration of a cocoa polyphenolic extract (Acti-
coa powder) on cognitive performances in aged rats. Br. J. Nutr. 100, 94–101. doi:
10.1017/S0007114507886375
Bowler, R. P., andCrapo, J. D. (2002). Oxidative stress in allergic respiratory diseases.
J. Allergy Clin. Immunol. 110, 349–356. doi: 10.1067/mai.2002.126780
Bravo, L. (1998). Polyphenols: chemistry, dietary sources, metabolism,
and nutritional signiﬁcance. Nutr. Rev. 56, 317–33 doi: 10.1111/j.1753-
4887.1998.tb01670.x
Frontiers in Pharmacology | Experimental Pharmacology and Drug Discovery December 2013 | Volume 4 | Article 154 | 6
“fphar-04-00154” — 2013/12/10 — 20:27 — page 7 — #7
Becker et al. Immunomodulatory properties of cacao extracts
Brigelius-Flohé, R., Kluth, D., and Banning, A. (2005). Is there a future for
antioxidants in atherogenesis? Mol. Nutr. Food Res. 49, 1083–1089. doi:
10.1002/mnfr.200500094
Capuron, L.,Neurauter,G.,Musselman,D. L., Lawson,D.H.,Nemeroff, C. B., Fuchs,
D., et al. (2003). Interferon-alpha-induced changes in tryptophan metabolism,
relationship to depression and paroxetine treatment. Mol. Psychiatry 9, 906–914.
doi: 10.1016/S0006-3223(03)00173-2
Capuron, L., Ravaud,A., Neveu, P. J.,Miller, A. H.,Maes,M., and Dantzer, R. (2002).
Association between decreased serum tryptophan concentrations and depressive
symptoms in cancer patients undergoing cytokine therapy. Mol. Psychiatry 5,
468–473. doi: 10.1038/sj.mp.4000995
Capuron, L., Schroecksnadel, S., Féart, C., Aubert, A., Higueret, D., Barberger-
Gateau, P., et al. (2011). Chronic low-grade inﬂammation in elderly persons is
associated with altered tryptophan and tyrosine metabolism: role in neuropsychi-
atric symptoms. Biol. Psychiatry 70, 175–82 doi: 10.1016/j.biopsych.2010.12.006
Cirillo, P., Pacileo, M., DE Rosa, S., Calabrò, P., Gargiulo, A., Angri, V.,
et al. (2006). Neopterin induces pro-atherothrombotic phenotype in human
coronary endothelial cells. J. Thromb. Haemost. 4, 2248–2255 doi: 10.1111/j.1538-
7836.2006.02125.x
Corti, R., Flammer, A. J., Hollenberg, N. K., and Lüscher, T. F. (2009). Cocoa and
cardiovascular health. Circulation 119, 1433–1441. doi: 10.1161/CIRCULATION-
AHA.108.827022
Dantzer, R., and Kelley, K. W. (2007). Twenty years of research on
cytokine-induced sickness behavior. Brain Behav. Immun. 21, 153–160. doi:
10.1016/j.bbi.2006.09.006
DeVane, C. L. (1998). Differential pharmacology of newer antidepressants. J. Clin.
Psychiatry 20, 85–93.
Engler, M. B., Engler, M. M., Chen, C. Y., Malloy, M. J., Browne, A., Chiu, E. Y.,
et al. (2004). Flavonoid-rich dark chocolate improves endothelial function and
increases plasma epicatechin concentrations in healthy adults. J. Am. Coll. Nutr.
23, 197–204. doi: 10.1080/07315724.2004.10719361
Fisher, N. D., Hughes, M., Gerhard-Herman, M., and Hollenberg, N. K. (2003).
Flavanol-rich cocoa induces nitric-oxide-dependent vasodilation in healthy
humans. J. Hypertens. 21, 2281–2286. doi: 10.1097/00004872-200312000-00016
Fuchs, D., Hausen, A., Huber, C., Margreiter, R., Reibnegger, G., Spielberger, M.,
et al. (1982). Pteridine secretion as a marker for the proliferation of alloantigen-
induced lymphocytes. Hoppe Seylers Z. Physiol. Chem. 363, 661–664.
Fuchs, D., Möller, A. A., Reibnegger, G., Stöckle, E., Werner, E. R., and Wachter, H.
(1990). Decreased serum tryptophan in patients with HIV-1 infection correlates
with increased serum neopterin and with neurologic/psychiatric symptoms. J.
Acquir. Immune Deﬁc. Syndr. 3, 873–876.
Fuchs, D., Weiss, G., Reibnegger, G., and Wachter, H. (1992). The role of neopterin
as a monitor of cellular immune activation in transplantation, inﬂammatory,
infectious, and malignant diseases. Crit. Rev. Clin. Lab. Sci. 29, 307–341. doi:
10.3109/10408369209114604
Galleano, M., Oteiza, P. I., and Fraga, C. G. (2009). Cocoa, chocolate,
and cardiovascular disease. J. Cardiovasc. Pharmacol. 54, 483–490. doi:
10.1097/FJC.0b013e3181b76787
Gershon, M. D., and Tack, J. (2007). The serotonin signaling system: from basic
understanding to drug development for functional GI disorders. Gastroenterology
132, 397–414. doi: 10.1053/j.gastro.2006.11.002
Grammer, T. B., Fuchs, D., Boehm, B. O., Winkelmann, B. R., and Maerz,
W. (2009). Neopterin as a predictor of total and cardiovascular mortality in
individuals undergoing angiography in the Ludwigshafen risk and cardiovas-
cular health study. Clin. Chem. 55, 1135–1146. doi: 10.1373/clinchem.2008.
118844
Grassi, D., Desideri, G., and Ferri, C. (2010). Blood pressure and cardiovascular
risk: what about cocoa and chocolate? Arch. Biochem. Biophys. 501, 112–115. doi:
10.1016/j.abb.2010.05.020
Heiss, C., Dejam, A., Kleinbongard, P., Schewe, T., Sies, H., and Kelm, M.
(2003). Vascular effects of cocoa rich in ﬂavan-3-ols. JAMA 290, 1030–1031.
doi: 10.1001/jama.290.8.1030
Heyes, M. P., Saito, K., Crowley, J. S., Davis, L. E., Demitrack, M. A., Der, M.,
et al. (1992). Quinolinic acid and kynurenine pathway metabolism in inﬂam-
matory and non-inﬂammatory neurological disease. Brain 115, 1249–1273. doi:
10.1093/brain/115.5.1249
Hoekstra, R., Fekkes, D., van de Wetering, B. J., Pepplinkhuizen, L., and Verhoeven,
W. M. (2003). Effect of light therapy on biopterin, neopterin and tryptophan
in patients with seasonal affective disorder. Psychiatry Res. 120, 37–42 doi:
10.1016/S0165-1781(03)00167-7
Hofmann, B., Bass, H., Nishanian, P., Faisal, M., Figlin, R. A., Sarna, G. P., et al.
(1992). Different lymphoid cell populations produce varied levels of neopterin,
beta 2-microglobulin and soluble IL-2 receptor when stimulated with IL-2,
interferon-gamma or tumour necrosis factor-alpha. Clin. Exp. Immunol. 88,
548–554. doi: 10.1111/j.1365-2249.1992.tb06485.x
Hronek, M., Zadak, Z., Solichova, D., Jandik, P., and Melichar, B. (2000). The asso-
ciation between speciﬁc nutritional antioxidants and manifestation of colorectal
cancer. Nutrition 16, 189–191. doi: 10.1016/S0899-9007(99)00285-3
Hurst,W. J., Tarka, S.M. Jr., Powis, T.G.,Valdez, F. Jr., andHester, T. R. (2002). Cacao
usage by the earliestMaya civilization.Nature 418, 289–290. doi: 10.1038/418289a
Jenny, M., Klieber, M., Zaknun, D., Schroecksnadel, S., Kurz, K., Ledochowski, M.,
et al. (2011). In vitro testing for anti-inﬂammatory properties of compounds
employing peripheral blood mononuclear cells freshly isolated from healthy
donors. Inﬂamm. Res. 60, 127–135. doi: 10.1007/s00011-010-0244-y
Jenny, M., Santer, E., Klein, A., Ledochowski, M., Schennach, H., Ueberall,
F., et al. (2009). Cacao extracts suppress tryptophan degradation of mitogen-
stimulated peripheral blood mononuclear cells. J. Ethnopharmacol. 122, 261–267
doi: 10.1016/j.jep.2009.01.011
Jin, B., Sun, T., Yu, X. H.,Yang,Y. X., andYeo,A. E. (2012). The effects of TLR activa-
tion onT-cell development and differentiation. Clin. Dev. Immunol. 2012:836485.
doi: 10.1155/2012/836485
Joshipura, K. J., Hu, F. B., Manson, J. E., Stampfer, M. J., Rimm, E. B., Speizer,
F. E., et al. (2001). The effect of fruit and vegetable intake on risk for coronary
heart disease. Ann. Intern. Med. 12, 1106–1114. doi: 10.7326/0003-4819-134-12-
200106190-00010
Keen, C. L., Holt, R. R., Oteiza, P. I., Fraga, C. G., and Schmitz, H. H. (2005). Cocoa
antioxidants and cardiovascular health. Am. J. Clin. Nutr. 81, 298–303.
Klein, C., Patte-Mensah, C., Taleb, O., Bourguignon, J. J., Schmitt, M., Bihel,
F., et al. (2013). The neuroprotector kynurenic acid increases neuronal cell
survival through neprilysin induction. Neuropharmacology 70, 254–260. doi:
10.1016/j.neuropharm.2013.02.006
Lucey, D. R., Clerici, M., and Shearer, G. M. (1996). Type 1 and type 2 cytokine
dysregulation in human infectious, neoplastic, and inﬂammatory diseases. Clin.
Microbiol. Rev. 9, 532–562.
Maes, M., Scharpé, S., Meltzer, H. Y., Okayli, G., Bosmans, E., D’Hondt,
P., et al. (1994). Increased neopterin and interferon-gamma secretion and
lower availability of L-tryptophan in major depression: further evidence for
an immune response. Psychiatry Res. 2,143–160. doi: 10.1016/0165-1781(94)
90003-5
Miller, K. B., Stuart, D. A., Smith, N. L., Lee, C. Y., McHale, N. L., Flana-
gan, J. A., et al. (2006). Antioxidant activity and polyphenol and procyanidin
contents of selected commercially available cocoa-containing and chocolate prod-
ucts in the United States. J. Agric. Food Chem. 54, 4062–4068. doi: 10.1021/
jf060290o
Mullen, W., Borges, G., Donovan, J. L., Edwards, C. A., Seraﬁni, M., Lean, M. E.,
et al. (2009). Milk decreases urinary excretion but not plasma pharmacokinetics
of cocoa ﬂavan-3-ol metabolites in humans. Am. J. Clin. Nutr. 89, 1784–1791.
doi: 10.3945/ajcn.2008.27339
Murr, C., Fuith, L. C., Widner, B., Wirleitner, B., Baier-Bitterlich, G., and Fuchs, D.
(1999). Increased neopterin concentrations in patients with cancer: indicator of
oxidative stress? Anticancer Res. 19, 1721–1728.
Murr, C., Widner, B., Sperner-Unterweger, B., Ledochowski, M., Schubert, C., and
Fuchs, D. (2000). Immune reaction links disease progression in cancer patients
with depression. Med. Hypotheses 2, 137–140. doi: 10.1054/mehy.1999.1043
Murr, C., Widner, B., Wirleitner, B., and Fuchs, D. (2002). Neopterin as a
marker for immune system activation. Curr. Drug Metab. 3, 175–187. doi:
10.2174/1389200024605082
Murr, C., Winklhofer-Roob, B. M., Schroecksnadel, K., Maritschnegg, M.,
Mangge, H., Bohm, B. et al. (2009). Inverse association between serum
concentrations of neopterin and antioxidants in patients with and with-
out angiographic coronary artery disease. Atherosclerosis 202, 543–549. doi:
10.1016/j.atherosclerosis.2008.04.047
Nathan, C. F. (1986). Peroxide and pteridine: a hypothesis on the regulation of
macrophage antimicrobial activity by interferon-gamma. Interferon 7, 125–143.
Neurauter, G., Schroecksnadel, K., Scholl-Bürg,i S., Sperner-Unterweger, B., Schu-
bert, C., Ledochowski, M., et al. (2008). Chronic immune stimulation correlates
www.frontiersin.org December 2013 | Volume 4 | Article 154 | 7
“fphar-04-00154” — 2013/12/10 — 20:27 — page 8 — #8
Becker et al. Immunomodulatory properties of cacao extracts
with reduced phenylalanine turnover. Curr. Drug Metab. 9, 622–627. doi:
10.2174/138920008785821738
Parker, G., Parker, I., and Brotchie, H. (2006). Mood state effects
of chocolate. J. Affect. Disord. 92, 149–159. doi: 10.1016/j.jad.2006.
02.007
Payne, M. J., Hurst, W. J., Miller, K. B., Rank, C., and Stuart, D. A. (2010). Impact of
fermentation, drying, roasting, andDutch processing on epicatechin and catechin
content of cacao beans and cocoa ingredients. J. Agric. Food Chem. 58, 10518–
10527. doi: 10.1021/jf102391q
Pedersen, E. R., Midttun, Ø., Ueland, P. M., Schartum-Hansen, H., Seifert, R.,
Igland, J., et al. (2011). Systemic markers of interferon-γ-mediated immune
activation and long-term prognosis in patients with stable coronary artery dis-
ease. Arterioscler. Thromb. Vasc. Biol. 31,698–704. doi: 10.1161/ATVBAHA.110.
219329
Pfefferkorn, E. R. (1986). Interferon-gamma and the growth of Toxoplasma gondii
in ﬁbroblasts. Ann. Inst. Pasteur. Microbiol. 137A, 348–352. doi: 10.1016/S0769-
2609(86)80047-3
Ramiro, E., Franch, A., Castellote, C., Pérez-Cano, F., Permanyer, J., Izquierdo-
Pulido, M., et al. (2005). Flavonoids from Theobroma cacao down-regulate
inﬂammatory mediators. J. Agric. Food Chem. 53, 8506–8511. doi: 10.1021/jf05
11042
Ramsey, S. A., Gold, E. S., Aderem, A. (2010). A systems biology
approach to understanding atherosclerosis. EMBO Mol. Med. 2, 79–89. doi:
10.1002/emmm.201000063
Rein, D., Paglieroni, T. G., Wun, T., Pearson, D. A., Schmitz, H. H., Gosselin, R.,
et al. (2000). Cocoa inhibits platelet activation and function. Am. J. Clin. Nutr.
72, 30–35.
Rios, L. Y., Bennett, R. N., Lazarus, S. A., Rémésy, C., Scalbert, A., and Williamson,
G. (2002). Cocoa procyanidins are stable during gastric transit in humans. Am. J.
Clin. Nutr. 76, 1106–1110.
Rodríguez-Ramiro, I., Ramos, S., Bravo, L., Goya, L., and Martín, M. Á. (2011).
Procyanidin B2 and a cacao polyphenolic extract inhibit acrylamide-induced
apoptosis in human Caco-2 cells by preventing oxidative stress and activation
of JNK pathway. J. Nutr. Biochem. 22, 1186–1194. doi: 10.1016/j.jnutbio.2010.
10.005
Romagnani, S. (2004). Immunologic inﬂuences on allergy and the TH1/TH2
balance. J. Allergy Clin. Immunol. 113, 395–400. doi: 10.1016/j.jaci.2003.11.025
Romagnani, S. (2006). Regulation of the T cell response. Clin. Exp. Allergy 36,
1357–1366. doi: 10.1111/j.1365-2222.2006.02606.x
Rusconi, M., and Conti, A. (2010). Theobroma cacao L., the Food of the Gods:
a scientiﬁc approach beyond myths and claims. Pharmacol. Res. 61, 5–13. doi:
10.1016/j.phrs.2009.08.008
Sas, K., Robotka, H., Toldi, J., and Vécsei, L. (2007). Mitochondria, metabolic
disturbances, oxidative stress and the kynurenine system, with focus on neu-
rodegenerative disorders. J. Neurol. Sci. 257, 221–239 doi: 10.1016/j.jns.2007.
01.033
Schroecksnadel, K., Fischer, B., Schennach, H., Weiss, G., and Fuchs, D. (2007).
Antioxidants suppress Th1-type immune response in vitro. Drug Metab. Lett. 1,
166–171 doi: 10.2174/187231207781369816
Schroecksnadel, K., Frick, B., Winkler, C., and Fuchs, D. (2006a). Cru-
cial role of interferon-gamma and stimulated macrophages in cardiovascular
disease. Curr. Vasc. Pharmacol. 4, 205–213. doi: 10.2174/1570161067776
98379
Schröcksnadel, K., Wirleitner, B., Winkler, C., and Fuchs, D. (2006b). Monitoring
tryptophan metabolism in chronic immune activation. Clin. Chim. Acta 364,
82–90. doi: 10.1016/j.cca.2005.06.013
Seraﬁni, M., Bugianesi, R., Maiani, G., Valtuena, S., De Santis, S., and
Crozier, A. (2003). Plasma antioxidants from chocolate. Nature 424:1013. doi:
10.1038/4241013a
Solà, R., Valls, R. M., Godàs, G., Perez-Busquets, G., Ribalta, J., Girona,
J., et al. (2012). Cocoa, hazelnuts, sterols and soluble ﬁber cream
reduces lipids and inﬂammation biomarkers in hypertensive patients: a ran-
domized controlled trial. PLoS ONE 7:31103. doi: 10.1371/journal.pone.
0031103
Spadafranca, A., Martinez, Conesa, C., Sirini, S., and Testolin, G. (2010). Effect of
dark chocolate on plasma epicatechin levels, DNA resistance to oxidative stress
and total antioxidant activity in healthy subjects. Br. J. Nutr. 103, 1008–1014. doi:
10.1017/S0007114509992698
Stevenson, D. E., and Hurst, R. D. (2007). Polyphenolic phytochemicals–
just antioxidants or much more? Cell. Mol. Life Sci. 64, 2900–2916. doi:
10.1007/s00018-007-7237-1
Surh, Y. J. (2003). Cancer chemoprevention with dietary phytochemicals. Nat. Rev.
Cancer 3,768–780. doi: 10.1038/nrc1189
van Dam, R. M., Naidoo, N., and Landberg, R. (2013). Dietary ﬂavonoids and
the development of type 2 diabetes and cardiovascular diseases: review of
recent ﬁndings. Curr. Opin. Lipidol. 24, 25–33. doi: 10.1097/MOL.0b013e32835
bcdff
van de Vijver, L. P., Kardinaal, A. F., Grobbee, D. E., Princen, H. M., and van
Poppel, G. (1997). Lipoprotein oxidation, antioxidants and cardiovascular risk:
epidemiologic evidence. Prostaglandins Leukot. Essent. Fatty Acids 57, 479–487.
doi: 10.1016/S0952-3278(97)90432-4
Weiss, G., Fuchs, D., Hausen, A., Reibnegger, G., Werner, E. R., Werner-
Felmayer, G., et al. (1993). Neopterin modulates toxicity mediated by reactive
oxygen and chloride species. FEBS Lett. 321, 89–92. doi: 10.1016/0014-5793(93)
80627-7
Weiss, G., Schwaighofer, H., Herold, M., Nachbaur, D., Wachter, H., Nieder-
wieser, D., et al. (1995). Nitric oxide formation as predictive parameter for acute
graft-versus-host disease after human allogeneic bone marrow transplantation.
Transplantation 60, 1239–1244.
Werner, E. R., Bichler, A., Daxenbichler, G., Fuchs, D., Fuith, L. C., Hausen, A., et al.
(1987). Determination of neopterin in serum and urine. Clin. Chem. 33, 62–66.
Werner, E. R., Werner-Felmayer, G., Fuchs, D., Hausen, A., Reib-
negger, G., and Wachter, H. (1989). Parallel induction of tetrahy-
drobiopterin biosynthesis and indoleamine 2,3-dioxygenase activity in
human cells and cell lines by interferon-gamma. Biochem. J. 262,
861–866.
Werner, E. R., Werner-Felmayer, G., Fuchs, D., Hausen, A., Reibnegger, G.,
Yim, J. J., et al. (1990). Tetrahydrobiopterin biosynthetic activities in human
macrophages, ﬁbroblasts, THP-1, and T 24 cells. GTP-cyclohydrolase I is stim-
ulated by interferon-gamma, and 6-pyruvoyl tetrahydropterin synthase and
sepiapterin reductase are constitutively present. J. Biol. Chem. 265, 3189–
3192.
Widner, B., Laich, A., Sperner-Unterweger, B., Ledochowski, M., and Fuchs, D.
(2002). Neopterin production, tryptophan degradation, and mental depression–
what is the link? Brain Behav. Immun. 16, 590–595. doi: 10.1016/S0889-
1591(02)00006-5
Widner, B., Wirleitner, B., Baier-Bitterlich, G., Weiss, G., and Fuchs, D. (2000).
Cellular immune activation, neopterin production, tryptophan degradation and
the development of immunodeﬁciency. Arch. Immunol. Ther. Exp. (Warsz) 48,
251–258.
Williams, C. D. (2013). Antioxidants and prevention of gastrointestinal
cancers. Curr. Opin. Gastroenterol. 2, 195–200. doi: 10.1097/MOG.
0b013e32835c9d1b
Winkler, C., Wirleitner, B., Schroecksnadel, K., Schennach, H., and Fuchs, D.
(2004). St. John’s wort (Hypericum perforatum) counteracts cytokine-induced
tryptophan catabolism in vitro. Biol. Chem. 385, 1197–1202. doi: 10.1515/BC.
2004.155
Zaknun, D., Schroecksnadel, S., Kurz, K., and Fuchs, D. (2012). Potential role
of antioxidant food supplements, preservatives and colorants in the patho-
genesis of allergy and asthma. Int. Arch. Allergy Immunol. 157,113–124. doi:
10.1159/000329137
Zeng, H., Locatelli, M., Bardelli, C., Amoruso, A., Coisson, J. D.,
Travaglia, F., et al. (2011). Anti-inﬂammatory properties of clovamide
and Theobroma cacao phenolic extracts in human monocytes: evalu-
ation of respiratory burst, cytokine release, NF-κB activation, and
PPARγ modulation. J. Agric. Food Chem. 59, 5342–5350. doi: 10.1021/
jf2005386
Zvetkova, E., Wirleitner, B., Tram, N. T., Schennach, H., and Fuchs, D.
(2001). Aqueous extracts of Crinum latifolium (L.) and Camellia sinensis
show immunomodulatory properties in human peripheral blood mononu-
clear cells. Int. Immunopharmacol. 1, 2143–2150. doi: 10.1016/S1567-5769(01)
00140-0
Conflict of Interest Statement: The authors declare that the researchwas conducted
in the absence of any commercial or ﬁnancial relationships that could be construed
as a potential conﬂict of interest.
Frontiers in Pharmacology | Experimental Pharmacology and Drug Discovery December 2013 | Volume 4 | Article 154 | 8
“fphar-04-00154” — 2013/12/10 — 20:27 — page 9 — #9
Becker et al. Immunomodulatory properties of cacao extracts
Received: 28 June 2013; accepted: 27 November 2013; published online: 12 December
2013.
Citation: Becker K,Geisler S,Ueberall F, FuchsD andGostner JM (2013) Immunomod-
ulatory properties of cacao extracts – potential consequences for medical applications.
Front. Pharmacol. 4:154. doi: 10.3389/fphar.2013.00154
This article was submitted to Experimental Pharmacology and Drug Discovery, a
section of the journal Frontiers in Pharmacology.
Copyright © 2013 Becker, Geisler, Ueberall, Fuchs and Gostner. This is an open-
access article distributed under the terms of the Creative Commons Attribution
License (CC BY). The use, distribution or reproduction in other forums is permit-
ted, provided the original author(s) or licensor are credited and that the original
publication in this journal is cited, in accordance with accepted academic practice.
No use, distribution or reproduction is permitted which does not comply with these
terms.
www.frontiersin.org December 2013 | Volume 4 | Article 154 | 9
